… and EMBASE using the terms “BRAF”, “BRAF mutation”, “BRAF V600E”, “cancer”, “…
meta-analysis on data reported in 30 independent studies, we evaluated the effect of BRAF-V600E …

… Our meta-analysis indicated that BRAF V600E mutation was significantly associated with
female, advanced disease stage, high T stage, proximal or right tumor location, poor tissue …

… In this meta-analysis, we examined whether the BRAF … This meta-analysis reveals that the
BRAF mutation is … Xing et al.14 reported that the BRAF mutation was significantly associated …

… meta-analysis of studies that compared BRAF inhibitor-based combination therapy with
BRAF … A combination therapy with BRAF inhibitors and MEK inhibitors was used in all studies. …

… BRAF patients over wild-type BRAF patients was 0.14 (95% CI = 0.04–0.53; P = 0.004). In
conclusion, this meta-analysis provides evidence that BRAF V600E … BRAF mutation may be …

… This meta-analysis demonstrated that BRAF V600E mutation was significantly correlated
with adverse pathological features of CRC and distinct clinical characteristics. These data …

… On the other hand, one interesting finding in the present meta-analysis was that the BRAF
V600E mutation was not related to distant metastasis. One potential reason for this result may …

… In summary, meta-analysis of the literature shows BRAF V600E mutation correlates with
poor prognostic features of PTC. Most studies, however, use disparate methods of BRAF …

… and specificity of the BRAF V600E mutation in predicting … We undertook a systematic
review and meta-analysis of the … the meta-analysis of the diagnostic accuracy of BRAF V600E …

… of RAS/BRAF/MAPK … , our meta-analysis indicates that the BRAF V600E mutation in PTC is
significantly associated with poor survival outcomes including OS and RFS. The BRAF V600E …